Thyrocare Technologies Limited — Others, 05-07-2025: Shareholders meeting

Thyrocare Technologies Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company delivered strong growth, with consolidated revenue rising 20.19% to ₹687.35 crore and profit after tax increasing 30% to ₹90.75 crore. Key developments include acquisitions of Polo Labs and Vimta Labs’ diagnostic businesses, enhancing regional presence in North and South India respectively. Thyrocare operates a network of 29 NABL-accredited labs, expanding diagnostic accessibility across 4,600+ pin codes and serving 16.7 million patients. The company supports ESG initiatives such as energy efficiency, waste management, workforce training, and community health programs. A final dividend of ₹21 per share is proposed.